- AU$9.98m
- AU$25.99m
- AU$8.67m
Brief: Curvebeam AI Seeks Trading Halt
Australia's CurveBeam AI shares double in value on FDA nod for CT scan tech
Australia's CurveBeam AI on track for best day in 3 weeks on premium placement
Brief: Curvebeam AI Secures A$5 Million Placement, A$1 Million Share Purchase Plan
Brief: Curvebeam AI Seeks Trading Halt
Brief: Curvebeam Ai Says FDA 510(K) Clearance For Bmd Module For Mdct Targeted For H2
Brief: Curvebeam Ai Loss For Half-Year Attributable A$9.8 Million
Australia's CurveBeam AI climbs to over 2-month high on Chinese investment approval
Brief: Curvebeam Ai Says Notified Of China Outbound Direct Investment Approval For Strategic Investment
Brief: Curvebeam AI Executes Definitive Agreements For Expansion Into China
Australia's Curvebeam AI logs record gains on China expansion
Brief: Curvebeam AI Seeks Trading Halt
Brief: Curvebeam AI Receives A$6.5 MLN Institutional Placement Commitments At A$0.09 Per Share
Australia's Curvebeam AI hits 8-week low on discounted placement
Brief: Curvebeam AI Seeks Trading Halt
Australia's Curvebeam AI drops as Bell Potter cuts PT pending HiRise validation
Brief: Curvebeam AI Says Loss For Year Attributable A$16.8 Million
Australia's CurveBeam AI rises as co fears no material impact from US tariffs
Brief: Curvebeam AI Expects No Material Adverse Effects From US Tariffs